Trial
NCT02967380
Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases
UnknownTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Southern California
Collaborators
National Cancer Institute (NCI)
Condition
Adult Anaplastic (Malignant) Meningioma
Intervention
Dynamic Contrast-Enhanced Magnetic Resonance Imaging
Why stopped
Insufficient Accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-03-27